Literature DB >> 4154121

Prevention of exercise-induced asthma by indoramin.

S Bianco, J P Griffin, P L Kamburoff, F J Prime.   

Abstract

Indoramin, an alpha-adrenoceptor blocking drug, has been found to prevent the occurrence of exercise-induced bronchoconstriction. Evidence is provided in two cases that this was not due to the antihistamine properties of indoramin.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4154121      PMCID： PMC1612123          DOI： 10.1136/bmj.4.5935.18

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  4 in total

1.  Changes in plasma concentration of epinephrine and norepinephrine with muscular work.

Authors:  I GRAY; W P BEETHAM
Journal:  Proc Soc Exp Biol Med       Date:  1957-12

2.  Clinical evaluation of indoramin, a new antihypertensive agent.

Authors:  P J Lewis; C F George; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

3.  Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine.

Authors:  A T Birmingham; J Szolcsányi
Journal:  J Pharm Pharmacol       Date:  1965-07       Impact factor: 3.765

4.  Pharmacologic studies of indoramin in man.

Authors:  R B Royds; D J Coltart; J D Lockhart
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875
  4 in total
  15 in total

1.  Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects.

Authors:  J G Maconochie; E P Woodings; D A Richards
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

2.  Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.

Authors:  V M Oh; C M Kaye; S J Warrington; E A Taylor; J Wadsworth
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

Review 3.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

4.  Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.

Authors:  C Clerici; A Harf; I Macquin-Mavier
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

5.  Failure of ejaculation with indoramin.

Authors:  B Pentland; D A Anderson; J A Critchley
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

6.  Plasma catecholamines in exercise induced bronchoconstriction.

Authors:  M Beil; H M Brecht; B Rasche
Journal:  Klin Wochenschr       Date:  1977-06-15

7.  Prazosin in the treatment of chronic asthma.

Authors:  S V Baudouin; T J Aitman; A J Johnson
Journal:  Thorax       Date:  1988-05       Impact factor: 9.139

8.  Inhaled prazosin in asthma.

Authors:  P J Barnes; P W Ind; C T Dollery
Journal:  Thorax       Date:  1981-05       Impact factor: 9.139

Review 9.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

10.  Growth hormone response to exercise in asthmatic and normal children.

Authors:  I Amirav; R J Dowdeswell; M Plit; V R Panz; B I Joffe; H C Seftel
Journal:  Eur J Pediatr       Date:  1990-03       Impact factor: 3.183
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.